Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

 0.16p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.01p
  • 52 Week Low: 0.12p
  • Currency: UK Pounds
  • Shares Issued: 2,295.93m
  • Volume: 29,115,498
  • Market Cap: £3.62m
  • Beta: 0.08

SVNS Overview

Our motto “COMBINE INCOMPATIBLE” defines the essence of our business which is to create polymer modifiers & alloys which combine immiscible and incompatible components of polymers to achieve a versatile range of mechanical characteristics including good impact and chemical resistance, fire retardant properties and cost-effectiveness.

Key Personnel

CEO: Anthony Tennyson
Chairman: Dennis Purcell
Finance Director: Ryan Neats
Independent Non-Executive Director: Renata Crome
Non-Executive Dir:

Contact Details

Address: Eccleston Yards, 25 Eccleston Place, London, United Kingdom, SW1W 9NF
Phone: +44 (0)20 4524 9900
Website: http://www.solvonis.com/

Listings

Sector: Pharma and Biotech(LSE)
ISIN: GB00BMD1Z199

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.16p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.01p
52 Week Low 0.12p
Volume 29,115,498
Shares Issued 2,295.93m
Market Cap £3.62m
Beta 0.08

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
25.23% below the market average25.23% below the market average25.23% below the market average25.23% below the market average25.23% below the market average
6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 02-Apr-2025

Time Volume / Share Price
16:09 682,578 @ 0.16p
14:24 185,000 @ 0.16p
13:32 5,000,000 @ 0.16p
13:20 3,426,770 @ 0.16p
12:26 1,000,000 @ 0.16p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell
Finance Director Ryan Neats

Top of Page